Correlation Between ATyr Pharma, and Adicet Bio

Can any of the company-specific risk be diversified away by investing in both ATyr Pharma, and Adicet Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATyr Pharma, and Adicet Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between aTyr Pharma, and Adicet Bio, you can compare the effects of market volatilities on ATyr Pharma, and Adicet Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATyr Pharma, with a short position of Adicet Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATyr Pharma, and Adicet Bio.

Diversification Opportunities for ATyr Pharma, and Adicet Bio

-0.5

Correlation Coefficient

ATyr Pharma,  Adicet Bio

Very good diversification

The 3 months correlation between ATyr and Adicet is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding aTyr Pharma, and Adicet Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adicet Bio and ATyr Pharma, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on aTyr Pharma, are associated (or correlated) with Adicet Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adicet Bio has no effect on the direction of ATyr Pharma, i.e., ATyr Pharma, and Adicet Bio go up and down completely randomly.

Pair Corralation between ATyr Pharma, and Adicet Bio

Given the investment horizon of 90 days aTyr Pharma, is expected to under-perform the Adicet Bio. In addition to that, ATyr Pharma, is 2.05 times more volatile than Adicet Bio. It trades about -0.12 of its total potential returns per unit of risk. Adicet Bio is currently generating about 0.05 per unit of volatility. If you would invest  60.00  in Adicet Bio on August 10, 2025 and sell it today you would earn a total of  4.00  from holding Adicet Bio or generate 6.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

aTyr Pharma,  vs.  Adicet Bio

aTyr Pharma,

Risk-Adjusted Performance

Weakest

Over the last 90 days aTyr Pharma, has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Adicet Bio

Risk-Adjusted Performance

Soft

Compared to the overall equity markets, risk-adjusted returns on investments in Adicet Bio are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent technical and fundamental indicators, Adicet Bio unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with ATyr Pharma, and Adicet Bio

The main advantage of trading using opposite ATyr Pharma, and Adicet Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATyr Pharma, position performs unexpectedly, Adicet Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adicet Bio will offset losses from the drop in Adicet Bio's long position.

The idea behind aTyr Pharma, and Adicet Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.